Search by Drug Name or NDC
NDC 43066-0021-10 Cardene IV 0.1 mg/mL Details
Cardene IV 0.1 mg/mL
Cardene IV is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is NICARDIPINE HYDROCHLORIDE.
Product Information
| NDC | 43066-0021 |
|---|---|
| Product ID | 43066-021_ad0477ba-841a-4f1f-af14-2c3229e83541 |
| Associated GPIs | 34000018142020 |
| GCN Sequence Number | 064304 |
| GCN Sequence Number Description | nicardipine in NaCl, iso-osm PIGGYBACK 20MG/200ML INTRAVEN |
| HIC3 | A9A |
| HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
| GCN | 12735 |
| HICL Sequence Number | 035779 |
| HICL Sequence Number Description | NICARDIPINE IN SODIUM CHLORIDE, ISO-OSMOTIC |
| Brand/Generic | Brand |
| Proprietary Name | Cardene IV |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | nicardipine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.1 |
| Active Ingredient Units | mg/mL |
| Substance Name | NICARDIPINE HYDROCHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019734 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43066-0021-10 (43066002110)
| NDC Package Code | 43066-021-10 |
|---|---|
| Billing NDC | 43066002110 |
| Package | 10 BAG in 1 CARTON (43066-021-10) / 200 mL in 1 BAG |
| Marketing Start Date | 2020-08-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |